{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:00:31Z","timestamp":1792119631905,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PDF-2018-11-ST2-006"],"award-info":[{"award-number":["PDF-2018-11-ST2-006"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rotavirus infection has been proposed as a risk factor for coeliac disease (CD) and type 1 diabetes (T1D). The UK introduced infant rotavirus vaccination in 2013. We have previously shown that rotavirus vaccination can have beneficial off-target effects on syndromes, such as hospitalised seizures. We therefore investigated whether rotavirus vaccination prevents CD and T1D in the UK.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cohort study of children born between 2010 and 2015 was conducted using primary care records from the Clinical Practice Research Datalink. Children were followed up from 6 months to 7 years old, with censoring for outcome, death or leaving the practice. CD was defined as diagnosis of CD or the prescription of gluten-free goods. T1D was defined as a T1D diagnosis. The exposure was rotavirus vaccination, defined as one or more doses. Mixed-effects Cox regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CIs). Models were adjusted for potential confounders and included random intercepts for general practices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 880,629 children in the cohort (48.8% female). A total of 343,113 (39.0%) participants received rotavirus vaccine; among those born after the introduction of rotavirus vaccination, 93.4% were vaccinated. Study participants contributed 4,388,355 person-years, with median follow-up 5.66 person-years. There were 1657 CD cases, an incidence of 38.0 cases per 100,000 person-years. Compared with unvaccinated children, the adjusted HR for a CD was 1.05 (95% CI 0.86\u20131.28) for vaccinated children. Females had a 40% higher hazard than males. T1D was recorded for 733 participants, an incidence of 17.1 cases per 100,000 person-years. In adjusted analysis, rotavirus vaccination was not associated with risk of T1D (HR = 0.89, 95% CI 0.68\u20131.19).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Rotavirus vaccination has reduced diarrhoeal disease morbidity and mortality substantial since licencing in 2006. Our finding from this large cohort study did not provide evidence that rotavirus vaccination prevents CD or T1D, nor is it associated with increased risk, delivering further evidence of rotavirus vaccine safety.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-021-02017-1","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T01:03:07Z","timestamp":1624928587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Thomas","family":"Inns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate M.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Iturriza-Gomara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9770-0163","authenticated-orcid":false,"given":"Daniel","family":"Hungerford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"2017_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","volume":"16","author":"P Singh","year":"2018","unstructured":"Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:823\u201336 e2.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2017_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/ajg.2014.55","volume":"109","author":"J West","year":"2014","unstructured":"West J, Fleming KM, Tata LJ, Card TR, Crooks CJ. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014;109(5):757\u201368. https:\/\/doi.org\/10.1038\/ajg.2014.55.","journal-title":"Am J Gastroenterol."},{"key":"2017_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou A, Gudbj\u00f6rnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. Type 1 diabetes mellitus. Nat Rev Dis Primer. 2017;3:1\u201317.","journal-title":"Nat Rev Dis Primer."},{"key":"2017_CR4","unstructured":"National Paediatric Diabetes Audit. National Paediatric Diabetes Audit Annual Report 2018-19. 2020. https:\/\/www.rcpch.ac.uk\/sites\/default\/files\/2020-03\/final_npda_core_report_2018-2019.pdf. Accessed 22 Jan 2021."},{"key":"2017_CR5","unstructured":"National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management [NG17]. 2015. https:\/\/www.nice.org.uk\/guidance\/ng17\/evidence\/full-guideline-pdf-435,400,241. Accessed 29 Apr 2021."},{"issue":"10","key":"2017_CR6","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1111\/j.1572-0241.2006.00741.x","volume":"101","author":"LC Stene","year":"2006","unstructured":"Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006;101(10):2333\u201340. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00741.x.","journal-title":"Am J Gastroenterol."},{"issue":"9","key":"2017_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030358","volume":"3","author":"G Zanoni","year":"2006","unstructured":"Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S, et al. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med. 2006;3(9):e358. https:\/\/doi.org\/10.1371\/journal.pmed.0030358.","journal-title":"PLoS Med."},{"key":"2017_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.virusres.2013.11.009","volume":"179","author":"JA Pane","year":"2014","unstructured":"Pane JA, Webster NL, Zufferey C, Coulson BS. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells. Virus Res. 2014;179:73\u201384. https:\/\/doi.org\/10.1016\/j.virusres.2013.11.009.","journal-title":"Virus Res."},{"issue":"8","key":"2017_CR9","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.2337\/diabetes.49.8.1319","volume":"49","author":"MC Honeyman","year":"2000","unstructured":"Honeyman MC, Coulson BS, Stone NL, Gellert SA, Goldwater PN, Steele CE, et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes. 2000;49(8):1319\u201324. https:\/\/doi.org\/10.2337\/diabetes.49.8.1319.","journal-title":"Diabetes."},{"issue":"12","key":"2017_CR10","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2337\/dc12-0423","volume":"35","author":"JK Snell-Bergeon","year":"2012","unstructured":"Snell-Bergeon JK, Smith J, Dong F, Bar\u00f3n AE, Barriga K, Norris JM, et al. Early childhood infections and the risk of islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetes Care. 2012;35(12):2553\u20138. https:\/\/doi.org\/10.2337\/dc12-0423.","journal-title":"Diabetes Care."},{"issue":"apr15 4","key":"2017_CR11","doi-asserted-by":"publisher","first-page":"f2347","DOI":"10.1136\/bmj.f2347","volume":"346","author":"M Iturriza-G\u00f3mara","year":"2013","unstructured":"Iturriza-G\u00f3mara M, Cunliffe N. Rotavirus vaccine: a welcome addition to the immunisation schedule in the UK. BMJ. 2013;346(apr15 4):f2347. https:\/\/doi.org\/10.1136\/bmj.f2347.","journal-title":"BMJ."},{"key":"2017_CR12","unstructured":"NHS Digital. Childhood Vaccination Coverage Statistics 2019-20. 2020. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/nhs-immunisation-statistics\/england%2D%2D-2019-20. Accessed 21 Jan 2021."},{"issue":"2","key":"2017_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/infdis\/jiv398","volume":"213","author":"CJ Atchison","year":"2016","unstructured":"Atchison CJ, Stowe J, Andrews N, Collins S, Allen DJ, Nawaz S, et al. Rapid declines in age group\u2013specific rotavirus infection and acute gastroenteritis among vaccinated and unvaccinated individuals within 1 year of rotavirus vaccine introduction in England and Wales. J Infect Dis. 2016;213(2):243\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiv398.","journal-title":"J Infect Dis."},{"issue":"1","key":"2017_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12916-017-0989-z","volume":"16","author":"D Hungerford","year":"2018","unstructured":"Hungerford D, Vivancos R, Read JM, Iturriza-G\u03ccmara M, French N, Cunliffe NA. Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK. BMC Med. 2018;16(1):10. https:\/\/doi.org\/10.1186\/s12916-017-0989-z.","journal-title":"BMC Med."},{"issue":"11","key":"2017_CR15","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/jech-2019-213055","volume":"73","author":"DJ Hungerford","year":"2019","unstructured":"Hungerford DJ, French N, Iturriza-G\u00f3mara M, Read JM, Cunliffe NA, Vivancos R. Reduction in hospitalisations for acute gastroenteritis-associated childhood seizures since introduction of rotavirus vaccination: a time-series and change-point analysis of hospital admissions in England. J Epidemiol Community Health. 2019;73(11):1020\u20135. https:\/\/doi.org\/10.1136\/jech-2019-213055.","journal-title":"J Epidemiol Community Health."},{"key":"2017_CR16","doi-asserted-by":"publisher","unstructured":"Inns T, Fleming KM, Iturriza-Gomara M, Hungerford D. Systematic review of the association between rotavirus infection, or rotavirus vaccination and coeliac disease. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.12.01.20241869.","DOI":"10.1101\/2020.12.01.20241869"},{"issue":"7","key":"2017_CR17","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/infdis\/jiaa168","volume":"222","author":"RM Burke","year":"2020","unstructured":"Burke RM, Tate JE, Jiang B, Parashar UD. Rotavirus and type 1 diabetes\u2014is there a connection? A synthesis of the evidence. J Infect Dis. 2020;222(7):1076\u201383. https:\/\/doi.org\/10.1093\/infdis\/jiaa168.","journal-title":"J Infect Dis."},{"issue":"3","key":"2017_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, Van Staa T, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827\u201336. https:\/\/doi.org\/10.1093\/ije\/dyv098.","journal-title":"Int J Epidemiol."},{"key":"2017_CR19","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyz034","volume":"48","author":"A Wolf","year":"2019","unstructured":"Wolf A, Dedman D, Campbell J, Booth H, Lunn D, Chapman J, et al. Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J Epidemiol. 2019;48:1740\u20131740\u2009g.","journal-title":"Int J Epidemiol"},{"issue":"45","key":"2017_CR20","doi-asserted-by":"publisher","first-page":"6674","DOI":"10.1016\/j.vaccine.2018.09.051","volume":"36","author":"D Hungerford","year":"2018","unstructured":"Hungerford D, Vivancos R, Read JM, Bonnett LJ, Bar-Zeev N, Iturriza-G\u00f3mara M, et al. Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: application to rotavirus vaccination in the UK. Vaccine. 2018;36(45):6674\u201382. https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.051.","journal-title":"Vaccine."},{"issue":"7","key":"2017_CR21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/aje\/kwu001","volume":"179","author":"CA Panozzo","year":"2014","unstructured":"Panozzo CA, Becker-Dreps S, Pate V, Weber DJ, Jonsson Funk M, St\u00fcrmer T, et al. Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010. Am J Epidemiol. 2014;179(7):895\u2013909. https:\/\/doi.org\/10.1093\/aje\/kwu001.","journal-title":"Am J Epidemiol."},{"issue":"7","key":"2017_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041308","volume":"7","author":"M Violato","year":"2012","unstructured":"Violato M, Gray A, Papanicolas I, Ouellet M. Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis. PLOS ONE. 2012;7(7):e41308. https:\/\/doi.org\/10.1371\/journal.pone.0041308.","journal-title":"PLOS ONE."},{"issue":"2","key":"2017_CR23","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1016\/S2589-7500(19)30012-3","volume":"1","author":"V Kuan","year":"2019","unstructured":"Kuan V, Denaxas S, Gonzalez-Izquierdo A, Direk K, Bhatti O, Husain S, et al. A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service. Lancet Digit Health. 2019;1(2):e63\u201377. https:\/\/doi.org\/10.1016\/S2589-7500(19)30012-3.","journal-title":"Lancet Digit Health."},{"key":"2017_CR24","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.4431770","volume-title":"Codes used to extract coeliac disease, type I diabetes, rotavirus vaccination and DTP vaccination from CPRD Aurum","author":"T Inns","year":"2020","unstructured":"Inns T. Codes used to extract coeliac disease, type I diabetes, rotavirus vaccination and DTP vaccination from CPRD Aurum; 2020. https:\/\/doi.org\/10.5281\/zenodo.4431770."},{"issue":"5","key":"2017_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/INF.0000000000002281","volume":"38","author":"M Hemming-Harlo","year":"2019","unstructured":"Hemming-Harlo M, L\u00e4hdeaho M-L, M\u00e4ki M, Vesikari T. Rotavirus vaccination does not increase type 1 diabetes and may decrease celiac disease in children and adolescents. Pediatr Infect Dis J. 2019;38(5):539\u201341. https:\/\/doi.org\/10.1097\/INF.0000000000002281.","journal-title":"Pediatr Infect Dis J."},{"issue":"10","key":"2017_CR26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/archdischild-2013-303996","volume":"98","author":"S Murch","year":"2013","unstructured":"Murch S, Jenkins H, Auth M, Bremner R, Butt A, France S, et al. Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children. Arch Dis Child. 2013;98(10):806\u201311. https:\/\/doi.org\/10.1136\/archdischild-2013-303996.","journal-title":"Arch Dis Child."},{"issue":"5","key":"2017_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/archdischild-2014-307105","volume":"100","author":"F Zingone","year":"2015","unstructured":"Zingone F, West J, Crooks CJ, Fleming KM, Card TR, Ciacci C, et al. Socioeconomic variation in the incidence of childhood coeliac disease in the UK. Arch Dis Child. 2015;100(5):466\u201373. https:\/\/doi.org\/10.1136\/archdischild-2014-307105.","journal-title":"Arch Dis Child."},{"key":"2017_CR28","unstructured":"Therneau TM. coxme: Mixed Effects Cox Models. 2020. https:\/\/CRAN.R-project.org\/package=coxme. Accessed 23 Jul 2020."},{"key":"2017_CR29","doi-asserted-by":"crossref","unstructured":"Therneau TM, Grambsch PM. The Cox model. In: Modeling survival data: extending the Cox model: Springer; 2000. p. 39\u201377.","DOI":"10.1007\/978-1-4757-3294-8_3"},{"key":"2017_CR30","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.cgh.2016.10.033","volume":"15","author":"KM Kemppainen","year":"2017","unstructured":"Kemppainen KM, Lynch KF, Liu E, L\u00f6nnrot M, Simell V, Briese T, et al. Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life. Clin Gastroenterol Hepatol. 2017;15:694\u2013702 e5.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"2017_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/INF.0000000000001600","volume":"36","author":"O Vaarala","year":"2017","unstructured":"Vaarala O, Jokinen J, Lahdenkari M, Leino T. Rotavirus vaccination and the risk of celiac disease or type 1 diabetes in Finnish children at early life. Pediatr Infect Dis J. 2017;36(7):674\u20135. https:\/\/doi.org\/10.1097\/INF.0000000000001600.","journal-title":"Pediatr Infect Dis J."},{"issue":"3","key":"2017_CR32","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamapediatrics.2018.4578","volume":"173","author":"KP Perrett","year":"2019","unstructured":"Perrett KP, Jachno K, Nolan TM, Harrison LC. Association of rotavirus vaccination with the incidence of type 1 diabetes in children. JAMA Pediatr. 2019;173(3):280\u20132. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.4578.","journal-title":"JAMA Pediatr."},{"issue":"1","key":"2017_CR33","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1038\/s41598-019-44193-4","volume":"9","author":"MAM Rogers","year":"2019","unstructured":"Rogers MAM, Basu T, Kim C. Lower Incidence Rate of Type 1 Diabetes after receipt of the rotavirus vaccine in the United States, 2001\u20132017. Sci Rep. 2019;9(1):7727. https:\/\/doi.org\/10.1038\/s41598-019-44193-4.","journal-title":"Sci Rep."},{"issue":"5","key":"2017_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jamapediatrics.2019.6324","volume":"174","author":"JM Glanz","year":"2020","unstructured":"Glanz JM, Clarke CL, Xu S, Daley MF, Shoup JA, Schroeder EB, et al. Association between rotavirus vaccination and type 1 diabetes in children. JAMA Pediatr. 2020;174(5):455\u201362. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.6324.","journal-title":"JAMA Pediatr."},{"issue":"4","key":"2017_CR35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jamapediatrics.2019.5513","volume":"174","author":"RM Burke","year":"2020","unstructured":"Burke RM, Tate JE, Dahl RM, Saydah S, Imperatore G, Gregg EW, et al. Rotavirus vaccination and type 1 diabetes risk among us children with commercial insurance. JAMA Pediatr. 2020;174(4):383\u20135. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.5513.","journal-title":"JAMA Pediatr."},{"issue":"2","key":"2017_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/cid\/cit671","volume":"58","author":"DC Payne","year":"2014","unstructured":"Payne DC, Baggs J, Zerr DM, Klein NP, Yih K, Glanz J, et al. Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis. 2014;58(2):173\u20137. https:\/\/doi.org\/10.1093\/cid\/cit671.","journal-title":"Clin Infect Dis."},{"key":"2017_CR37","doi-asserted-by":"publisher","unstructured":"Mellone NG, Silva MT, Paglia MDG, Lopes LC, Barberato-Filho S, de S\u00e1 Del Fiol F, et al. Kawasaki disease and the use of the rotavirus vaccine in children: a systematic review and meta-analysis. Front Pharmacol. 2019;10. https:\/\/doi.org\/10.3389\/fphar.2019.01075.","DOI":"10.3389\/fphar.2019.01075"},{"issue":"9626","key":"2017_CR38","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(08)60765-5","volume":"371","author":"V Harjutsalo","year":"2008","unstructured":"Harjutsalo V, Sj\u00f6berg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet. 2008;371(9626):1777\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(08)60765-5.","journal-title":"Lancet."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02017-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02017-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02017-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T01:03:22Z","timestamp":1624928602000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02017-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2017"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02017-1","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this research was given by the Independent Scientific and Ethical Committee (ISAC) of the CPRD (reference 20_024RA2). CPRD obtains annual rolling ethical approval (reference number 05\/MRE04\/87) and no additional ethical approval was required for this project which meets ISAC requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DH and MIG report grants on the topic of rotavirus vaccines, outside of the submitted work, from GlaxoSmithKline Biologicals, Sanofi Pasteur and Merck and Co (Kenilworth, NJ, USA) after the closure of Sanofi Pasteur-MSD in December 2016. MIG also reports personal fees for consultancy, outside the submitted work, from GlaxoSmithKline Biologicals. TI and KF have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}